ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2024

Remdesivir-Associated Survival Outcomes Among Immunocompromised Patients Hospitalized for COVID-19: Real-world Evidence From the Omicron-Dominant Era.

Essy Mozaffari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.